An investigation on behalf of investors in UnitedHealth Group Inc (NYSE:UNH) shares over potential wrongdoing at UnitedHealth Group was announced and NYSE:UNH stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 11/03/2016 -- Certain directors of UnitedHealth Group Inc are under investigation over potential wrongdoing. The investigation was announced for current long-term investors in NYSE:UNH shares over potential breaches of fiduciary duties by certain directors at UnitedHealth Group.
Investors who purchased shares of UnitedHealth Group Inc (NYSE:UNH) and currently hold any of those NYSE:UNH shares have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call 858-779-1554.
The investigation by a law firm concerns whether certain UnitedHealth Group directors breached their fiduciary duties and caused damage to the company and its shareholders.
Recently as consumer class action lawsuit was filed against UnitedHealth Group, Inc., United Healthcare Services, Inc., UnitedHealthcare of Alabama, Inc., and OptumRX, Inc.
According to the complaint the defendants are health insurance companies along with pharmacy benefit managers, that are retained by the health insurance companies, on behalf of the plan or third-party payors, to provide the pharmacy benefits to plan members, which includes, inter alia, establishing a formulary of drugs that will be covered, a network of pharmacies that will serve as participating pharmacies for plan participants to obtain their prescriptions, copayment amounts, coinsurance amounts, and deductibles.
According to the complaint the Defendants allegedly engaging in a scheme to defraud plan members by artificially inflating the copayment of medically necessary prescription drugs well above the cost of the drug.
The plaintiff alleges that certain plan participants pay inflated copayments to participating pharmacies in exchange for receiving their prescription drugs and that unbeknownst to the plan participants, Defendants allegedly artificially inflate the purported costs of the prescription drugs in the form of increased copayments and then "claw back," or recoup, from the pharmacies a large portion of the copayments.
On November 2, 2016, NYSE:UNH shares closed at $138.98 per share.
Those who purchased shares of UnitedHealth Group Inc have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego